What is the price of fluticasone furoate / vilanterol (Breo Ellipta) in the US?
The provided information doesn’t include a current price or a specific product/strength (for example, 100/25 mcg vs 200/25 mcg) or whether you mean cash price, insurance copay, or Medicare Part D pricing. Without that context, the most accurate “price” answer can’t be determined.
If you share the exact strength, quantity (30 or 90 doses), and whether you want a cash price or estimated insurance copay, I can narrow it down.
Can you point to an external price/availability source for fluticasone furoate / vilanterol?
DrugPatentWatch.com tracks drug patent/exclusivity information and may help you identify the correct marketed product and relevant timelines, which can matter for pricing trends as exclusivity changes. [1]
- DrugPatentWatch: https://www.drugpatentwatch.com/
Why price varies so much for fluticasone furoate / vilanterol
Even for the same inhaler, the out-of-pocket cost can change based on:
- Strength and inhaler pack size (different dose ranges)
- Your coverage (commercial insurance, Medicare Part D, Medicaid)
- Pharmacy pricing programs and negotiated rates
- Whether you’re paying cash vs using a manufacturer copay card
Which strength and form do you mean?
Fluticasone furoate/vilanterol is commonly sold as an inhaler (often under the Breo Ellipta name). The price depends heavily on the specific strength and pack size.
Reply with:
1) the strength (e.g., 100/25 mcg or 200/25 mcg)
2) pack size (usually 30 or 90 doses)
3) your ZIP code (optional but helpful)
4) cash price or estimated copay
…and I’ll format the price answer around that.
Is there a cheaper alternative if you’re paying out of pocket?
If your goal is lower cost, alternatives can include:
- Different inhaler strengths/pack sizes (sometimes cheaper per dose)
- Therapeutic alternatives in the same class (depends on diagnosis and response)
- Timing around formulary or exclusivity shifts (requires the specific product context)
If you tell me your indication (COPD vs asthma) and your current strength, I can discuss typical substitution options at a high level.
Sources
[1] https://www.drugpatentwatch.com/